Cite
HARVARD Citation
Rocconi, R. et al. (n.d.). 15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients. International journal of gynecological cancer. pp. A11-A12. [Online].